How to Choose a GLP-1 Provider as a Woman

Start with your own picture, not the ad

Most GLP-1 marketing is written as if every body is the same. Women's bodies are not, and the questions that decide whether a program is right for you are specific: Do you have PCOS or insulin resistance? Are you in the menopause transition? Do you rely on the pill for contraception, or might you want to conceive in the next year? A provider worth choosing will ask these things before it sells you anything. This guide is a checklist for finding one — it is educational only and not medical advice.

Hormonal suitability comes first

For many women, the reason GLP-1 weight will not shift is hormonal and metabolic at once. Insulin resistance sits behind much of PCOS weight and androgen excess, which is exactly the machinery these medicines act on³. A good provider treats that as central — it can talk through whether both semaglutide and tirzepatide are options, how treatment might affect your cycle, and where a GLP-1 fits alongside anything else you take. Our deeper GLP-1 and PCOS guide covers that suitability conversation in detail.

The four things to check

First, clinical oversight: a licensed clinician should review your history and be reachable when side effects or titration questions come up — not just at signup. Second, labs: ask whether baseline and follow-up bloodwork is included or expected, since that is how metabolic care is done safely; our labs and monitoring guide lists what to ask for. Third, molecule access: programs that offer both semaglutide and tirzepatide let a clinician match the drug to you rather than to their inventory. Fourth, honest pricing: the total monthly cost, what happens at higher doses, and whether you are locked into a long prepayment — see our cost and safe-start guide.

Why oversight beats the lowest price

The cheapest sticker price usually buys the least oversight, and for women that trade-off matters more, not less — because contraception, pregnancy planning and thyroid or metabolic markers all sit in the picture⁴. The large obesity trials show what well-run treatment can do: about 15% mean weight loss with semaglutide¹ and around 20% with tirzepatide². Those results came from monitored programs, and they are the standard our Luna Fit Score methodology is built to reward. Compare programs on oversight and hormonal fit first, then on price.